All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional
A Sub Study to Learn About the Study Medication Called Etrasimod Tablets in a Hybrid Decentralized Clinical Trial Setting
At a glance
Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Pfizer Inc.
Enrolment target
8
Start
26 Oct 2023
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (1)
- —Belgium
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.